SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ligand Pharmaceuticals Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 – LGND

NEW YORK, Nov. 21, 2016 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Ligand Pharmaceuticals Inc. (“Ligand”) (NASDAQ: LGND ) between November 9, 2015 and November 14, 2016 . You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of California. To get more information go to :

http://www.zlk.com/pslra/ligand-pharmaceuticals

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that during the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Ligand overstated the value of certain Deferred Tax Assets by approximately $27.5 million; (2) Ligand’s outstanding convertible senior unsecured notes due 2019 should have been classified as short-term debt rather than long-term debt as of December 31, 2015; (3) Ligand did not maintain effective controls over the accuracy and presentation of the accounting for income taxes related to complex transactions; (4) in turn, Ligand lacked effective internal control over financial reporting; and (5) as a result, Defendants’ statements about Ligand’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

If you suffered a loss in Ligand you have until January 17, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:    Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004            Tel: (212) 363-7500 Toll Free:  (877) 363-5972 Fax: (212) 363-7171 www.zlk.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Latino Real Estate Agents Lead Growth Amid Market Challenges

Updated Category News Views 289

NAHREP’s Top 250 Latino Agents Report Highlights Industry Trends The National Association of Hispanic Real Estate Professionals (NAHREP) recently published its annual Top 250 Latino Agents Report, showcasing the incredible achievements of 778 exceptional Latino real estate agents across the country. Despite the real estate market facing considerable struggles, these top...

Continue Reading
Exploring the Expanding Landscape of Satellite Internet Services

Updated Category News Views 241

Revolutionizing Connectivity: The Satellite Internet Industry "The global satellite internet market is expanding as satellites provide high-speed internet access to even the most remote areas." The satellite internet market has seen tremendous growth recently, highlighting the need for high-speed connectivity in every corner of the globe. As the landscape evolves,...

Continue Reading
Interfor's Strategic Lumber Production Adjustments Ahead

Updated Category News Views 221

Interfor Adjusts Lumber Production for Market Conditions In a recent announcement, Interfor Corporation (TSX: IFP), a leading player in the forest products industry, shared its plans to modify lumber production strategies for the upcoming quarter. The adjustments come amid continuing challenges in market demand and economic fluctuations affecting the timber sector....

Continue Reading
Sage Therapeutics to Share Q3 2024 Financial Insights Soon

Updated Category News Views 87

Sage Therapeutics Plans Upcoming Financial Webcast Sage Therapeutics, Inc. (NASDAQ: SAGE) is gearing up for a significant event by announcing that it will host a live webcast to discuss its financial performance for the third quarter of 2024. Scheduled for a future date, this presentation aims to give insights into the company's financial results and convey important...

Continue Reading
Covenant Health Data Breach: What Affected Customers Need to Know

Updated Category News Views 114

Covenant Health Data Breach Investigation Recent developments have emerged concerning a significant data breach at Covenant Health, Inc. This incident has caught the attention of many, especially those affected by the breach. The investigation into these claims is led by the dedicated law firm Edelson Lechtzin LLP. They are focused on addressing the privacy concerns of...

Continue Reading